Comparison of survival outcomes among cancer patients treated in and out of clinical trials. - Wikidata - wikimedia - TriplyDB

Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

http://www.wikidata.org/entity/Q37696455

about

sameAs

A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical Trials Enhancing cancer registry data for comparative effectiveness research (CER) project: overview and methodology.International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer Can quality of life assessments differentiate heterogeneous cancer patients?Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies.Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2388 health care providers Drugs, cancer and end-of-life care: a case study of pharmaceuticalization?Comparative effectiveness research in gynecologic oncology.How much do cancer-related symptoms contribute to health-related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium.Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.From evidence to clinical practice in blood and marrow transplantation A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results.Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer.The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials.Clinical utility of the Revised International Staging System in unselected patients with newly diagnosed and relapsed multiple myeloma Pemetrexed for ovarian cancer: a systematic review of the published literature and a consecutive series of patients treated in a nonclinical trial setting.Renal effects of targeted anticancer therapies.The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.The future of trials in surgical oncology.Adolescent and young adult patients with cancer: a milieu of unique features.Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature.Early mortality and overall survival of acute myeloid leukemia based on facility type.Why take part in personalised cancer research? Patients' genetic misconception, genetic responsibility and incomprehension of stratification-an empirical-ethical examination.Telehealth models could be extended to conducting clinical trials-a teletrial approach.Non-recruitment to and selection bias in studies using echocardiography in hemodialysis patients.Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens.A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden.The challenges of symptom management for patients with multimorbidity in research and practice: a thematic review.Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials.Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.Improving the accrual of racial and ethnic minority patients in clinical trials: Time to raise the stakes.Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials.Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?Clinical trial insurance coverage for cancer patients under the Affordable Care Act.Perceptions and attitudes toward clinical trials in adolescent and young adults with cancer: a systematic review.

P2860

Q28551817-0E767ED2-3B14-45B1-989B-AD3EC39E0EDF Q30871265-5CF4B293-BB3E-4C3E-8125-4D3E17504165 Q33660380-6EA31E03-14E4-4DB7-A2B4-4FC6D084BA8F Q33740600-F421989A-14CA-4E1A-890D-EA12BDECC656 Q33816983-2E09BD05-A3C0-4FBB-9110-066D6A9952F1 Q33865329-7862093C-C67F-4EC7-94FB-6AE8C977076A Q34921738-CECF6F87-B2F9-4A36-A2F6-ADB12100A82E Q35223735-AF8FA3C0-C3B8-4F58-8D9B-6F89998C678A Q35793038-C502C6CD-D0A3-4598-84C1-11505EC4E384 Q35930475-1D909469-3D11-4F47-985A-154096853197 Q36011137-88B22FC6-66CA-427C-B405-D63B999EE17D Q36055266-0B479E58-7456-4023-96C3-BB88845E7D1D Q36176911-ED5DB234-02FE-40FD-A8B4-26F22F697487 Q36759996-3AA1CA31-53D2-4EC7-A708-D81F49E3933B Q36932625-55EC1518-8214-4919-B856-AC1C2990A1C3 Q37095602-C2921AD3-D2DF-4F11-9167-E90458C7F8D1 Q37744801-0480408E-FC54-47E5-87E5-5CA91F24D769 Q38251598-8E67F4A4-B3F3-4E71-8D3C-F74B27CCB938 Q38367168-501FF0D3-6ED7-42FB-9C06-817DF960AF73 Q38375972-DB314054-1617-4B8B-A631-A2951366F15F Q38419183-92CC112F-E364-492B-8683-A73181EE0539 Q38502885-A652D0B4-B140-49E2-B316-FA9BFDFFEA7F Q38730792-7D57D8AC-7EF4-425A-9226-FBF4E7D456E3 Q38822583-C5D3278D-CB1F-4C30-AFAA-1A3C50E62EE5 Q38832807-FE4C8FD6-D6E8-41E4-B295-12FB0ED128CF Q39417841-ABCE5225-972E-4806-9109-28BDE04D0394 Q39547691-A5CDDDC8-6962-4049-ACA1-5C9E55B9FF0D Q40071391-39592229-574E-4ECF-A4F6-D3820442EE75 Q40122611-BA80D8D4-A925-4E82-AF04-C1BAE78A8286 Q40895560-42469DBA-56E2-4371-9BCF-BFAE47587DE0 Q41669687-8E14831F-E79C-4216-880A-1D79C61F521A Q41690271-DCC09094-D551-4D4F-A490-BACAB2F89CB7 Q43638078-084A7011-8FAD-4414-8FB8-CC0082D703BF Q46093492-92541803-CEF3-4DA2-A5F4-25BE2F2E16B6 Q48124116-57A25EDF-1269-4267-9424-D383203763C9 Q48165118-4AFA4810-D291-4930-935A-045C775D29AD Q53280595-A6A2197F-A25D-48B1-9108-B43A4F40C028 Q54996768-6008544E-E3E1-466C-94FF-5E2D37CA4543 Q55002577-BFE7018D-9739-4AA0-82D4-AF5D8BFFE08B Q55361068-1D546432-AAAF-4726-B286-369BD463A504

P2860

Comparison of survival outcomes among cancer patients treated in and out of clinical trials.

http://www.wikidata.org/entity/Q37696455

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparison of survival outcome ...... in and out of clinical trials.

@en

Comparison of survival outcome ...... in and out of clinical trials.

@nl

type

label

Comparison of survival outcome ...... in and out of clinical trials.

@en

Comparison of survival outcome ...... in and out of clinical trials.

@nl

altLabel

Comparison of survival outcome ...... in and out of clinical trials

@en

prefLabel

Comparison of survival outcome ...... in and out of clinical trials.

@en

Comparison of survival outcome ...... in and out of clinical trials.

@nl

P1433

Q37696455-9DBFCA6C-AD3F-4ED7-AEC1-0A0214E372AD

P1476

Q37696455-63DA3B7B-CA4D-46E8-90D3-9A41D95DEB25

Q37696455-DDDDCF51-60CB-434A-B610-801F01F14803

P2093

Q37696455-03E5EF01-2DF7-4E87-960D-E8217C9A49C6

Q37696455-048549AA-03FF-46A6-BA59-8A3CB12AC1C6

Q37696455-30A39970-F30D-4C3F-86E3-7327F7E50007

Q37696455-4643A8CF-4A2F-4037-AA1C-B40FF419CFAD

Q37696455-68BB9DCD-C925-450D-B9BF-E3D8177F4C55

Q37696455-87AFBAEB-23E6-4A97-9981-624EC2E75D51

Q37696455-95A12FEE-2B4D-4DC1-953A-FEFA59C89C5F

Q37696455-9A7AB4EF-F701-4C09-AF8A-6F8BDB08048E

Q37696455-9DD0C780-7B29-49DF-89B2-FF0A29D12F4B

Q37696455-9E569D39-A2D0-4D61-B55A-240CF2C6F6C4

P2860

Q37696455-0D0B0D55-D83C-422F-8282-6D777BBAB26C

Q37696455-0EECEFEB-BC7F-40EF-9211-704A66EE8B0C

Q37696455-180784A4-CEA7-4048-87CC-BF446A253DC5

Q37696455-1EAF0C36-C91E-4612-96F5-8A49CF56AB2C

Q37696455-256BAD06-A829-426B-BB5D-D4EF6AFC3A7F

Q37696455-28821A17-F66D-4401-A33A-F0ED30426D4C

Q37696455-2B12331A-21EF-4269-BBA4-CF8E15CD39A7

Q37696455-30366914-73AC-44D7-80FF-FD0044BB680E

Q37696455-34C2B50F-5AEF-4D09-A48A-CA689204C18A

Q37696455-3C27D3CF-C730-4DCD-8237-17A8CD680D91

P2880

Q37696455-837E93C3-B5A0-4DD8-A8B7-50B5BF45430B

P304

Q37696455-35624D46-6B40-4CB6-958A-7F1948BD2C71

P31

Q37696455-5B810240-75E5-4BBA-8800-25F6A3043931

P356

Q37696455-BEA43E05-E126-408B-A8D5-C90AC62F6DBB

P407

Q37696455-02E7927F-EB71-4F04-8C34-A0E1F64698D2

P433

Q37696455-D653E8E2-4F65-4CD4-AA73-8697E2224D29

P478

Q37696455-34441472-2E0B-49D2-9259-C24202A2B23F

P577

Q37696455-38DF853A-F98A-4807-8B7A-BCE4CC14221B

Q37696455-40F8E42F-C377-4A54-AE87-3637B29E6AE9

P5875

Q37696455-81E3F158-3A14-4B33-9F33-A47C68AF38EC

P698

Q37696455-474A4FD4-329F-4155-833D-FD7735DD5C67

P859

Q37696455-2F2F7586-73BD-4084-B87E-36E3F5B970F0

P921

Q37696455-717EED57-D99B-42A0-97BA-61C758E4764F

Q37696455-85D672AC-986A-4EE7-84AA-6D36988C06BD

P932

Q37696455-7F85CAED-A93C-45AB-A9CB-4FCED4290A1E

P356

P1433

Journal of the National Cancer Institute

P1476

Comparison of survival outcome ...... in and out of clinical trials

@en

Comparison of survival outcome ...... in and out of clinical trials.

@en

P2093

Barlow WE

http://www.w3.org/2001/XMLSchema#string

Dawn L Hershman

http://www.w3.org/2001/XMLSchema#string

Diane P Martin

http://www.w3.org/2001/XMLSchema#string

Etzioni R

http://www.w3.org/2001/XMLSchema#string

Hershman DL

http://www.w3.org/2001/XMLSchema#string

Joseph M Unger

http://www.w3.org/2001/XMLSchema#string

Leblanc M

http://www.w3.org/2001/XMLSchema#string

Martin DP

http://www.w3.org/2001/XMLSchema#string

Michael Leblanc

http://www.w3.org/2001/XMLSchema#string

Ramsey SD

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

Ethical issues in the design and conduct of randomised controlled trials.

Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial.

Survival from acute non-lymphocytic leukaemia, 1971-88: a population based study.

Barriers to participation in randomised controlled trials: a systematic review.

Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial

P2880

20057199

http://www.w3.org/2001/XMLSchema#string

P304

dju002

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJU002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2014-03-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260810277

http://www.w3.org/2001/XMLSchema#string

P698

24627276

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

P932

3982777

http://www.w3.org/2001/XMLSchema#string